<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>bacterial cancer therapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/bacterial-cancer-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 09 Oct 2026 01:27:11 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>bacterial cancer therapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>NIH Backs $13.1 Million Effort to Attack Breast Cancer with Engineered Salmonella</title>
		<link>https://bioengineer.org/nih-backs-13-1-million-effort-to-attack-breast-cancer-with-engineered-salmonella/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Fri, 09 Oct 2026 01:27:11 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[bacterial cancer therapy]]></category>
		<category><![CDATA[drug resistance]]></category>
		<category><![CDATA[Genetic engineering]]></category>
		<category><![CDATA[immunotherapy]]></category>
		<category><![CDATA[NIH grant]]></category>
		<category><![CDATA[oncolytic viruses]]></category>
		<category><![CDATA[PET imaging]]></category>
		<category><![CDATA[radiopharmaceutical therapy]]></category>
		<category><![CDATA[Salmonella]]></category>
		<category><![CDATA[triple-negative breast cancer]]></category>
		<category><![CDATA[UMass Amherst]]></category>
		<category><![CDATA[Weill Cornell Medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=409039</guid>

					<description><![CDATA[A five-year, $13.1 million NIH grant will fund engineered, nontoxic Salmonella designed to deliver radiopharmaceutical therapy, viral payloads, and immune-targeting strategies against drug-resistant triple-negative breast cancer.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">409039</post-id>	</item>
	</channel>
</rss>
